SEARCH

SEARCH BY CITATION

References

  • Arnout, J. (1996) The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 75, 536541.
  • Asherson, R.A., Khamashta, M., Ordi-Ros, J., Derksen, R.H.W.M., Machin, S.J., Barquinero, J., Outt, H.H., Harris, E.N., Vilardell-Torres, M., Hughes, G.R.V. (1989) The ‘primary’ antiphospholipid syndrome: major clincial and serological features. Medicine (Baltimore), 68, 366374.
  • Berman, C.L., Yeo, E.L., Wencel-Drake, J., Furie, B.C., Ginsberg, M.H., Furie, B. (1986) A platelet alpha-granule protein that is associated with the plasma membrane after activation: characterisation and subcellular localisation of platelet-activation dependent granule-external membrane protein. Journal of Clinical Investigation, 78, 130137.
  • Bevers, E.M., Comfurius, P., Zwaal, R.F.A. (1983) Changes in membrane phospholipid distribution during platelet activation. Biochimistry Biophysica Acta, 736, 5766.
  • Bihour, C., Durrieu-Jais, C., Besse, P., Nurden, P., Nurden, A.T. (1995) Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction. Blood Coagulation and Fibrinolysis, 6, 395410.
  • British Committee on Standards in Haematology (1991) Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party of the BCSH Haemostasis and Thrombosis Task Force. Journal of Clinical Pathology, 44, 885889.
  • Combes, V., Dignat-George, F., Mutin, M., Sampol, J. (1997) A new flow cytometry method of platelet-derived microvesicle quantitation in plasma. Thrombosis and Haemostasis, 77, 220.
  • Dunlop, L.C., Skinner, M.P., Bendall, L.J., Favoloro, E.J., Castaldi, P.A., Gorman, J.J., Gamble, J.R., Vadas, M.A., Berndt, M.C. (1992) Characterization of GMP-140 (P-selectin) as a circulating plasma protein. Journal of Experminetal Medicine, 175, 11471150.
  • Esmon, N.L., Smirnov, M.D., Esmon, C.T. (1997) Thrombogenic mechanisms of antiphospholipid antibodies. Thrombosis and Haemostasis, 78, 7982.
  • Fanelli, A., Bergamini, C., Rapi, S., Caldini, A., Spinelli, A., Buggiani, A., Emmi, L. (1997) Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies. Lupus, 6, 261267.
  • Forastiero, R., Martinuzzo, M., Carreras, L.O., Maclouf, J. (1998) Anti-beta2 glycoprotein I. antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. Thrombosis and Haemostasis, 79, 4245.
  • Furman, M.I., Benoit, S.E., Barnard, M.R., Valeri, C.R., Borbone, M.L., Becker, R.C., Hechtman, H.B., Michelson, A.D. (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of American College of Cardiology, 31, 352358.
  • Galli, M., Grassi, A., Barbui, T. (1993) Platelet-derived microvesicles in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 69, 541(Abstract).
  • Harris, E.N. (1987) Syndrome of the black swan. British Journal of Rheumatology, 26, 324326.
  • Harris, E.N., Gharavi, A.E., Patel, S.P., Hughes, G.R.V. (1987) Evaluation of the anticardiolipin test: report of an international workshop held 4 April 1986. Clinical and Experimental Immunology, 68, 215222.
  • Joseph, J.E., Donohoe, S., Harrison, P., Mackie, I.J., Machin, S.J. (1998) Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus, 7, 333340.
  • Li, N., Goodall, A.H., Hjemdahl, P. (1997) A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. British Journal of Haematology, 99, 808816.
  • McEver, R.P. (1991) Leukocyte interactions mediated by selectins. Thrombosis and Haemostasis, 66, 8087.
  • McNally, T., Mackie, I.J., Machin, S.J., Isenberg, D.A. (1995) Increased levels of β2 glycoprotein-I antigen and β2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. British Journal of Rheumatology, 34, 10311036.
  • Martinuzzo, M.E., Maclouf, J., Carreras, L.O., Levy-Toledano, S. (1993) Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thrombosis and Haemostasis, 70, 667671.
  • Metcalfe, P., Williamson, L.M., Reutelingsperger, C.P., Swann, I., Ouwehand, W.H., Goodall, A.H. (1997) Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. British Journal of Haematology, 98, 8695.
  • Michelson, A.D., Barnard, M.R., Hechtman, H.B., MacGregor, H., Connolly, R.J., Loscalzo, J., Valeri, C.R. (1996) In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proceedings of the National Academy of Sciences of the United States of America., 93, 1187711882.
  • Nieuwenhuis, H.K., Van Oosterhout, J.J., Rozemuller, E., Van Iwaarden, F., Sixma, J.J. (1987) Studies with a monoclonal antibody against activated platelets. evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood, 70, 838845.
  • Nishibori, M., Cham, B., McNicol, A., Shalev, A., Jain, N., Gerrard, J.M. (1993) The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky–Pudlak syndrome, and appears identical to granulophysin. Journal of Clinical Investigation, 91, 17751782.
  • Owens, M.R. (1994) The role of platelet microparticles in hemostasis. Transfusion Medicine Reviews, 8, 3744.
  • Petri, M. (1997) Pathogenesis and treatment of the antiphospholipid antibody syndrome. Medical Clinics of North America, 81, 151177.
  • Rand, J.H., Wu, X.X., Andree, H.A., Ross, J.B., Rusinova, E., Gascon-Lema, M.G., Calandri, C., Harpel, P.C. (1998) Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids. a ‘lupus procoagulant’ phenomenon. Blood, 92, 16521660.
  • Rinder, H.M., Bonan, J.L., Rinder, C.S., Ault, K.A., Smith, B.R. (1991a) Dynamics of leukocyte-platelet adhesion in whole blood. Blood, 78, 17301737.
  • Rinder, H.M., Bonan, J.L., Rinder, C.S., Ault, K.A., Smith, B.R. (1991b) Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood, 78, 17601769.
  • Rinder, H.M., Tracey, J.L., Rinder, C.S., Leitenberg, D., Smith, B.R. (1994) Neutrophil but not monocyte activation inhibits P-selectin mediated platelet adhesion. Thrombosis and Haemostasis, 71, 750756.
  • Rooney, A.M., McNally, T., Mackie, I.J., Machin, S.J. (1994) The taipan snake venom time: a new test for lupus anticoagulant. Journal of Clinical Pathology, 47, 497501.
  • Ruf, A., Pick, M., Deutsch, V., Patscheke, H., Goldfarb, A., Rachmilewitz, E.A., Guillin, M.C., Eldor, A. (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. British Journal of Haematology, 98, 5156.
  • Santoro, S. (1994) Antiphospholipid antibodies and thrombotic predisposition. underlying pathogenetic mechanisms. Blood, 83, 23892391.
  • Shattil, S.J., Hoxie, J.A., Cunningham, M., Brass, L.F. (1985) Changes in the platelet membrane glycoprotein IIb. IIIa complex during platelet activation. Journal of Biological Chemistry, 260, 1110711114.
  • Shattil, S.J., Cunningham, M., Hoxie, J.A. (1987) Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry. Blood, 70, 307315.
  • Silverstein, R.L. & Nachman, R.L. (1987) Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. Journal of Clinical Investigation, 79, 867874.
  • Specker, C., Perniok, A., Brauckmann, U., Siebler, M., Schneider, M. (1998) Detection of cerebral microemboli in APS – introducing a novel investigation method and implications of analogies with carotid artery disease. Lupus, 7, S75S80.
  • Stenberg, P.E., McEver, R.P., Shuman, M.A., Jacques, Y.V., Bainton, D.F. (1985) A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. Journal of Cell Biology, 101, 880886.
  • Thiagarajan, P. & Tait, J.F. (1990) Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. Journal of Biological Chemistry, 265, 1742017423.
  • Triplett, D.A. (1993) Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause? Archives of Pathology and Laboratory Medicine, 117, 7888.
  • Wiener, H.M., Vardinon, N., Yust, I. (1991) Platelet antibody binding and spontaneous aggregation in 21 lupus anticoagulant patients. Vox Sanguinis, 61, 111121.
  • Zwaal, R.F.A., Comfurius, P., Bevers, E.M. (1992) Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochimistry and Biophysical Acta, 1180, 18 .